Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genetic screens discover proteases as synthetic lethal partners of PI3K inhibition in breast cancer cells

ABSTRACT: Genetic screens discover proteases as synthetic lethal partners of PI3K inhibition in breast cancer cells

PROVIDER: PRJNA772940 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16495866_1.fastq.gz	Fastqsanger.gz
	SRR16495866_2.fastq.gz	Fastqsanger.gz
	SRR16495867_1.fastq.gz	Fastqsanger.gz
	SRR16495867_2.fastq.gz	Fastqsanger.gz
	SRR16495868_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 54

Similar Datasets

Genetic screens discover proteases as synthetic lethal partners of PI3K inhibition in breast cancer cells

Project description:The RNA-Seq analysed the changes in protease gene expression upon short-term PI3K inhibition in three breast cancer cell lines.

2021-12-31 | GSE186196 | GEO

Pooled CRISPR screens in human intestinal organoids [CRISPR screens]

Project description:We performed CRISPR screens on both a sub-library and a genome-wide scale in human intestinal organoids to discover cancer driver genes. We investigated the Wnt and the TGFB pathway and used both WT, APC-mutant and APC-TP53-mutant organoids.

2020-02-26 | GSE145184 | GEO

Combining deep-sequencing, proteomics, phosphoproteomics and functional screens to discover novel regulators of sphingolipids homeostasis.

Project description:Sphingolipids (SLs) are essential components of cell membranes and broad-range bioactive signaling molecules. SL levels must be tightly regulated as imbalances affect cellular function and contribute to pathologies ranging from neurodegenerative and metabolic disorders to cancer and aging. Deciphering how SL homeostasis is maintained and uncovering new regulators are two key aspects for understanding lipid biology and defining opportunities for therapeutic interventions. Here we combine multiple systematic technologies to identify the changes of the transcriptome, proteome and phosphoproteome in the yeast Saccharomyces cerevisiae upon SL depletion by myriocin. Surprisingly we find that SL depletion triggers only small changes on the expression and steady-state levels of regulatory proteins of SL homeostasis. However dramatic regulation occurs at level of the phosphoproteome suggesting that maintaining SL homeostasis demands rapid responses that cannot occur at the transcriptional level. To discover which of the phosphoproteomic changes are required for the cell’s first-line response to SL depletion and which are the bi-product of the cellular changes occurring following SL alterations, we combined the results with systematic growth screens for genes required during growth in myriocin when either mutated or overexpressed. By following the rate of SL biosynthesis in those candidates that are both essential for growth during myriocin and are phosphorylated in response to the drug we uncovered new regulators of SL homeostasis.

2017-05-04 | PXD003463 | Pride

Pooled CRISPR screens in human intestinal organoids [RNA-seq]

2020-02-26 | GSE145308 | GEO

Pooled CRISPR screens in human intestinal organoids [CUT&RUN]

2020-02-26 | GSE145183 | GEO

Pooled CRISPR screens in human intestinal organoids [ATAC-seq]

2020-02-26 | GSE145182 | GEO

NHLBI TOPMed: Partners HealthCare Biobank

Project description:NHLBI TOPMed: Partners HealthCare Biobank

| PRJNA300701 | ENA

Effect of proteases on soil

Project description:Effect of proteases on soil: Bioestimulation and Microbial Biodiversity

| PRJEB35654 | ENA

G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells

Project description:Neurofibromatosis Type II is a genetic condition caused by loss of the NF2 gene, resulting in activation of the YAP/TAZ pathway and recurrent growth of benign tumors from Schwann cells, the glia of the peripheral nervous system. Unfortunately, no pharmacological therapy is currently available for NFII. Here, we undertake a genome-wide CRISPR/cas9 screen to search for synthetic-lethal genes that, when inhibited, cause death of NF2 mutant cells but not NF2 wildtype cells. We thereby identify ACSL3 and G6PD as two synthetic-lethal partners for NF2. We find that NF2 mutant Schwann cells are vulnerable to G6PD inhibition because they have low levels of ME1. G6PD and ME1 redundantly generate cytosolic NADPH needed by cells to fight oxidative stress. Lack of either one of the two is compatible with cell viability, but down-regulation of both leads to Schwann cell death. Since genetic deficiency for G6PD is tolerated in the human population, this raises the possibility that G6PD could be a pharmacological target for NFII.

2024-04-24 | GSE219136 | GEO

G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells

2024-04-24 | GSE219135 | GEO